[Current status of the treatment of diabetic retinopathy].
D045930:Anabolic Agents / Q000627:therapeutic use; D002794:Choline / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007834:Lasers; D008028:Light Coagulation; D008715:Methionine / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use; D014978:Xenon
D045930:Anabolic Agents; D003911:Dextrans; D014815:Vitamins; D014978:Xenon; D008715:Methionine; D002994:Clofibrate; D002794:Choline
Estado actual del trataiento dela retinopatía diabética.